Navigation Links
Molecular Diagnostics Market: 5 Things You Need to Know
Date:6/14/2019

Molecular diagnostics segment is the fastest-growing segment within the global IVD market. The global market is estimated to be $8,760 million in 2019. Major segments that are expected to drive the growth are infectious diseases, cancer, and transplant diagnostics.

These are all broken out and forecasted as segments in Kalorama’s The World Molecular Diagnostics Market, 8th Edition.

The discovery of the structure of DNA in 1953 is one of the earliest scientific advancements that facilitated the development of molecular methods as diagnostic tools, even though it took more than 4 decades for the first tests to get commercialized. The pioneers in the molecular diagnostics field include Roche Diagnostics, Gen-Probe and Becton Dickinson. HIV and STDs were initially the most successful products. Now molecular Dx has many applications.

Kalorama Information made the following findings about the market in its report:

  • Fast Growth: The global market is forecasted to grow at a compound average growth rate (CAGR) of 8.1% to reach $12,955 million in 2024.
  • Microbiology leads: Infectious diseases diagnostics represent the largest market within, accounting for more than half of the global molecular diagnostics market.
  • Watch Reimbursements: Even though the demand for molecular diagnostic tests is growing at a high single-digit growth rate in spite of affordability concerns, reimbursement has been a major factor for this segment. This is particularly true in the case of tests for supporting drug decisions.
  • IT is Central: Molecular diagnostics market is evolving with the effective integration of information technology (IT) including various bioinformatics platforms, cloud computing and big data analysis methods. From data sharing to develop well-curated gene variations to integration of clinical insights for better outcomes, to development of automated sample-to-insight systems, only improved information technology will enable the realization of these concepts.
  • Watch NGS: Though a small segment now, we are right on the cusp of next-generation sequencing becoming an essential part of clinical decision making. Clinical usage is behing many installations and consumable purchases and have been touted by the major sequencing providers.

Kalorama Information's report is available at: https://kaloramainformation.com/product/the-world-molecular-diagnostics-market-8th-edition/

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.

Read the full story at https://www.prweb.com/releases/molecular_diagnostics_market_5_things_you_need_to_know/prweb16379881.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Molecular Devices Announces the Appointment of Susan Murphy as President
2. Molecular Devices Features FLIPR 1536-well Application in High-throughput Screening in Educational Webinar
3. Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019
4. Report: Hologic, Abbott, Roche and Qiagen Lead Molecular Testing
5. Researchers uncover new evidence revealing molecular paths to autism
6. Elsevier announces launch of open journal: Biomolecular Detection and Quantification
7. Study examines type of exome sequencing and molecular diagnostic yield
8. Molecular probes permit doctors to detect diabetic retinopathy before vision fails
9. MARC travel awards announced for GSA: Mouse Molecular Genetics Conference
10. Kalorama Report: Sizable Number of Acquisitions and Joint Ventures in Molecular Diagnostics
11. Team determines structure of a molecular machine that targets viral DNA for destruction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2019)... ... July 09, 2019 , ... Murrieta Genomics, a launch pad ... The founder and CEO of Tx Genetic, Helen Harrison, has spent several years ... epithelial connective tissue disorders. , “We are pleased and excited to join the ...
(Date:6/25/2019)... (PRWEB) , ... June 25, 2019 , ... ... 23andMe customers. Using 23andMe raw data, easily available from 23andMe, customers can get ... This new service is available for both 23andMe Ancestry and Health + Ancestry ...
(Date:6/16/2019)... ... 14, 2019 , ... Respected periodontist, Dr. Dan Holtzclaw, was ... World Congress. Attended by thousands of dental clinicians from all over the world, ... of dentistry. The three-day event featured a team of expert speakers from over ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... Iowa (PRWEB) , ... July 08, 2019 , ... Today, ... Moines, Iowa, the National Corn Growers Association (NCGA) announced the winners of ... to improve a product or process using field corn to produce biobased materials. , ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, ... Drug (IND) application to the FDA for use of a person’s own adipose-derived stem ... treatment of osteoarthritis in the knee. This IND is the first of several ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... from the USPTO providing proprietary interest to our methodology, processes, and diagnostic ... DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring ...
Breaking Biology Technology: